Publications by authors named "Christopher A Todd"

Claim this Profile
I
Immunogenicity of adjuvanted versus high-dose inactivated influenza vaccines in older adults: a randomized clinical trial.
Kenneth E Schmader, Christine K Liu, Brendan Flannery, Wes Rountree, Heidi Auerbach, Christopher A Todd

Immun Ageing· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an international external quality assurance program for HIV-1 incidence using the Limiting Antigen Avidity assay.
Sheila M Keating, Wes Rountree, Eduard Grebe, Andrea L Pappas, Mars Stone, Christopher A Todd

PLoS One· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fever After Influenza, Diphtheria-Tetanus-Acellular Pertussis, and Pneumococcal Vaccinations.
Emmanuel B Walter, Nicola P Klein, A Patricia Wodi, Wes Rountree, Christopher A Todd

Pediatrics· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Group B Streptococcus (GBS) Colonization and Disease among Pregnant Women: A Historical Cohort Study.
James M Edwards, Nora Watson, Chris Focht, Clara Wynn, Christopher A Todd

Infect Dis Obstet Gynecol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of antipyretics on immune response and fever following receipt of inactivated influenza vaccine in young children.
Emmanuel B Walter, Christoph P Hornik, Lisa Grohskopf, Charles E McGee, Christopher A Todd

Vaccine· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of Good Clinical Laboratory Practice (GCLP) guidelines within the External Quality Assurance Program Oversight Laboratory (EQAPOL).
Christopher A Todd, Ana M Sanchez, Ambrosia Garcia, Thomas N Denny, Marcella Sarzotti-Kelsoe

J Immunol Methods· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1.
Marcella Sarzotti-Kelsoe, Robert T Bailer, Ellen Turk, Chen-li Lin, Miroslawa Bilska, Christopher A Todd

J Immunol Methods· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization and validation of a neutralizing antibody assay for HIV-1 in A3R5 cells.
Marcella Sarzotti-Kelsoe, Xiaoju Daniell, Christopher A Todd, Miroslawa Bilska, Amanda Martelli

J Immunol Methods· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International technology transfer of a GCLP-compliant HIV-1 neutralizing antibody assay for human clinical trials.
Daniel A Ozaki, Hongmei Gao, Christopher A Todd, Kelli M Greene, David C Montefiori

PLoS One· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and implementation of an international proficiency testing program for a neutralizing antibody assay for HIV-1 in TZM-bl cells.
Christopher A Todd, Kelli M Greene, Xuesong Yu, Daniel A Ozaki, Hongmei Gao

J Immunol Methods· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilization of immunoglobulin G Fc receptors by human immunodeficiency virus type 1: a specific role for antibodies against the membrane-proximal external region of gp41.
Lautaro G Perez, Matthew R Costa, Christopher A Todd, Barton F Haynes, David C Montefiori

J Virol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis